Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Alumis Inc. before investing.

In this article, we go over a few key elements for understanding Alumis Inc.’s stock price such as:

• Alumis Inc.’s current stock price and volume
• Why Alumis Inc.’s stock price changed recently
• Upgrades and downgrades for ALMS from analysts
• ALMS’s stock price momentum as measured by its relative strength

About Alumis Inc. (ALMS)

Before we jump into Alumis Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company offers envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor that is in Phase 1 for the treatment of neuroinflammatory and neurodegenerative diseases. It also develops lonigutamab, a monoclonal antibody targeting IGF-1R for the treatment of thyroid eye diseases; and interferon regulatory factor 5 (IRF5) to address immune dysfunction. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022. Alumis Inc. was incorporated in 2021 and is headquartered in South San Francisco, California.

Want to learn more about Alumis Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Alumis Inc..

Alumis Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Alumis Inc.’s stock price was $28.250.

Alumis Inc. is down 2.42% from its previous closing price of $28.950.

During the last market session, Alumis Inc.’s stock traded between $27.565 and $29.200. Currently, there are approximately 125.05 million shares outstanding for Alumis Inc..

Alumis Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Alumis Inc. Stock Price History

Alumis Inc.’s (ALMS) price is currently up 0.39% so far this month.

During the month of July, Alumis Inc.’s stock price has reached a high of $31.350 and a low of $25.481.

Over the last year, Alumis Inc. has hit prices as high as $31.350 and as low as $3.760. Year to date, Alumis Inc.’s stock is up 189.45%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Alumis Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were 0 analysts who downgraded Alumis Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Alumis Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Alumis Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Alumis Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Alumis Inc. (ALMS) by visiting AAII Stock Evaluator.

Relative Price Strength of Alumis Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Alumis Inc. has a weighted four-quarter relative price strength of 87.37%, which translates to a Momentum Score of 100 and is considered to be Very Strong.

Want to learn more about how Alumis Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Alumis Inc. Stock Price: Bottom Line

As of July 31, 2026, Alumis Inc.’s stock price is $28.250, which is down 2.42% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Alumis Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.